Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

April 17, 2019April 17, 2019

Entyvio Improves Quality of Life, Work Productivity of Ulcerative Colitis Patients, Phase 3 Study Shows

News

Treatment with Entyvio (vedolizumab), delivered into the blood or under the skin, led to significant clinical improvements and in quality of life, as well as work productivity in patients with ... Read more

March 22, 2019March 26, 2019

Ozanimod Lessens Inflammation in Crohn’s, Early Phase 2 Trial Data Show

News

Daily treatment with 1 mg of ozanimod reduced gut inflammation in patients with moderately to severely active Crohn’s disease, early data from the phase 2 STEPSTONE study show. B.G. ... Read more

March 11, 2019March 11, 2019

Plant-based Fasting-Mimicking Diet May Help Lessen IBD Severity

News

A short-term, plant-based fasting-mimicking diet followed by a normal diet lessened several of the hallmarks of inflammatory bowel disease (IBD), a study in a mouse model shows. The study, ... Read more

February 11, 2019February 11, 2019

‘Carbohydrate Monotony’ Diet May Ease IBD, Researchers Propose

News

A diet rich in multiple carbohydrate sources, including sugars, starchy carbohydrates, and dietary fiber, is a likely perpetrator of inflammatory bowel disease (IBD), two researchers believe. They say the ... Read more

January 28, 2019January 28, 2019

Pseudopolyps Do Not Predict Colorectal Cancer Risk in IBD Patients, 20-year Retrospective Study Shows

News

Pseudopolyps — large protrusions of the intestinal layer formed in the regenerative and healing phases of damaged tissue — are not predictors of risk for developing colorectal cancer among patients with ... Read more

January 9, 2019January 9, 2019

Malnutrition Puts Children with Crohn’s at Higher Risk of Post-surgery Complications, Study Says

News

Worsening degrees of malnutrition are directly linked to a higher risk of 30-day complications in children with Crohn’s disease who have undergone major bowel surgery, a study says. The ... Read more

January 2, 2019January 2, 2019

Immunic Will Develop IMU-856, Promising IBD Therapy

News

Immunic earned the exclusive rights to develop a group of innovative disease-modifying therapies, now renamed IMU-856, for inflammatory bowel disease (IBD). IMU-856, originally developed by Daiichi Sankyo, is an oral ... Read more

November 28, 2018November 28, 2018

Cosentyx May Increase Risk for Inflammatory Bowel Disease, Italian Researchers Say

News

Italian researchers are calling attention to what they say is an alarming number of newly diagnosed cases of inflammatory bowel disease (IBD) in people treated with the human monoclonal ... Read more

November 16, 2018November 16, 2018

Crohn’s and Ulcerative Colitis Prevalence in Canada — Already High — Will Almost Double by 2030, Report Warns

News

Canada has the world’s highest prevalence of the two main forms of inflammatory bowel disease (IBD) — Crohn’s disease and ulcerative colitis — and the incidence of IBD is increasing ... Read more

November 2, 2018November 2, 2018

Antibiotic Use May Promote IBD Development by Disrupting Gut Immune Cells, Mouse Study Suggests

News

Antibiotics can disrupt immune cells residing in the gut, triggering the rise of pro-inflammatory cells and reducing healthy bacteria — two steps key in the development of inflammatory bowel ... Read more